The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Biotechnology costs in Mexico compared to the United States as of 2014
Biotechnology cost comparison Mexico vs United States 2014
This statistic compares the biotechnology costs in Mexico with costs in the United States, as of 2014. In all three segments - research and development, clinical trials of new products, and finished product testing - costs are significantly lower in Mexico than in the United States.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Biotechnology industry expenses in Spain 2022, by nature of the expense
- Premium Statistic Public U.S. biotech companies R&D spending by region 2021
- Premium Statistic U.S. bioscience venture capital investments 2009-2023
- Basic Statistic U.S. bioscience establishments totals 2019-2023
- Premium Statistic U.S. biotech industry R&D expense
- Premium Statistic Number of U.S. bioscience establishments by subsectors 2023
- Basic Statistic Biotech company R&D expenditure by country and by application 2014
- Basic Statistic Changes in European and U.S. biotech companies market cap 2019-2024
- Basic Statistic Market cap CAGR of biotech companies in the U.S. 2012-2016
- Premium Statistic Active biopharmaceuticals ingredients in development Germany 2018
About the region
10
- Premium Statistic Number of CDMO merger and acquisition deals worldwide by region 2017-2021
- Premium Statistic Value of CDMO merger and acquisition deals worldwide by region 2017-2021
- Premium Statistic Estimated market size of biologics CDMO worldwide 2025-2031
- Premium Statistic Percentage return on R&D among large cap biopharma companies 2010-2020
- Basic Statistic Global licensing and acquisitions for emerging therapeutic companies 2010-2019
- Premium Statistic Cost to bring large cap biopharmaceutical assets to market 2010-2020
- Basic Statistic Net income of Syneos Health 2013-2022
- Basic Statistic Number of startups using AI in drug discovery worldwide 2019, by area of discovery
- Premium Statistic Impact of COVID-19 on revenue of hospitality and retail sector South Korea 2020
- Basic Statistic Global Biopharma sector value, 2003-2021
Selected statistics
10
- Premium Statistic Biotechnology capital expenses in Spain 2022, by type
- Basic Statistic Value of completed European biopharma company trade sales 2009-2019
- Basic Statistic Production value of the Spanish biotech sector in relation to GDP 2010-2022
- Premium Statistic Amgen research and development expenditure 2006-2025
- Basic Statistic Amgen expenditure on research and development by category 2020-2025
- Basic Statistic Production value of the Spanish biotech sector 2010-2022
- Basic Statistic Capital increases in publicly traded biotech companies in Spain 2023, by company
- Basic Statistic Private capital increases in Spanish biotech companies 2016-2023
- Basic Statistic Number of cell and gene therapy deals worldwide 2016-2020, by type
- Premium Statistic Top global biotech companies — R&D expenditure 2024
Other regions
10
- Basic Statistic Expedited drug approvals by firms from California 2014-2019
- Basic Statistic Share of total business expenditure on technology R&D in Australia 2014
- Premium Statistic Total R&D costs of select cancer drugs 2017
- Basic Statistic Drug products in the pipeline in California 2020, by therapeutic area
- Basic Statistic Leading U.S. states by healthcare VC investment deals 2022
- Premium Statistic Size of U.S. CRO market 2024 vs. 2031
- Premium Statistic Revenue as a part of R&D spending for select cancer drugs 2017
- Basic Statistic Healthcare deals quarterly U.S. 2017-2020, by value
- Premium Statistic Revenue since approval for select cancer drugs 2017
- Premium Statistic Type 2 diabetes clinical pipeline in the U.S. in 2018, by type and phase
Related statistics
10
- Premium Statistic Market size of branded biopharmaceuticals in China 2013-2023
- Basic Statistic Largest biotech financing deals in the United States in Q4 2020, by company
- Basic Statistic Leading venture capital firms in U.S. healthcare in Q4 2020, by number of deals
- Basic Statistic Public grants for R&D in biotechnology Spain 2012-2021
- Basic Statistic Number of M&A healthcare deals in California and the U.S. in 2021, by sector
- Premium Statistic R&D intensity in the biotechnology business sector in Spain 2010-2021
- Basic Statistic Biotech company R&D expenditure selected countries by firm size 2014
- Premium Statistic Patients in clinical trials in selected European countries 2005-2011
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Basic Statistic Biotechnology companies: number of employees in Germany 2008-2024
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
ProMéxico. (September 30, 2014). Biotechnology costs in Mexico compared to the United States as of 2014 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 26, 2026, from /statistics/478818/mexico-biotechnology-cost-comparison-with-us/
ProMéxico. "Biotechnology costs in Mexico compared to the United States as of 2014." Chart. September 30, 2014. ÌÇÐÄÆƽâ°æ. Accessed July 26, 2026. /statistics/478818/mexico-biotechnology-cost-comparison-with-us/
ProMéxico. (2014). Biotechnology costs in Mexico compared to the United States as of 2014. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 26, 2026. /statistics/478818/mexico-biotechnology-cost-comparison-with-us/
ProMéxico. "Biotechnology Costs in Mexico Compared to The United States as of 2014." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 30 Sep 2014, /statistics/478818/mexico-biotechnology-cost-comparison-with-us/
ProMéxico, Biotechnology costs in Mexico compared to the United States as of 2014 ÌÇÐÄÆƽâ°æ, /statistics/478818/mexico-biotechnology-cost-comparison-with-us/ (last visited July 26, 2026)
Biotechnology costs in Mexico compared to the United States as of 2014 [Graph], ProMéxico, September 30, 2014. [Online]. Available: /statistics/478818/mexico-biotechnology-cost-comparison-with-us/
Advertisement